Literature DB >> 26982451

Fecal microbiota transplantation in children: a brief review.

Suchitra K Hourigan1,2,3,4, Maria Oliva-Hemker2.   

Abstract

There has been a growing interest in fecal microbiota transplantation (FMT) over recent years, in part due to the increasing prevalence of Clostridium difficile infection (CDI) and expanding association of intestinal dysbiosis with a wide range of human diseases. Many adult studies have shown that FMT is an effective treatment for recurrent CDI and may possibly have applications in other illnesses such as inflammatory bowel disease (IBD); however, there is a paucity of data available in children who may differ from adults for many reasons including having a dynamic developing microbiome compared to adults who have a relatively stable microbiome. Here, we review published studies looking at FMT in children, for CDI and IBD, and discuss special considerations needed when conducting FMT in children.

Entities:  

Mesh:

Year:  2016        PMID: 26982451     DOI: 10.1038/pr.2016.48

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  60 in total

Review 1.  Gut microbiome, obesity, and metabolic dysfunction.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Authors:  Ethan Gough; Henna Shaikh; Amee R Manges
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

3.  Fecal microbiota transplantation in children with recurrent Clostridium difficile infection.

Authors:  Anne Pierog; Ali Mencin; Norelle Rizkalla Reilly
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

4.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Pediatric Patients: Encouragement Wrapped in Caution.

Authors:  Susan V Lynch
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

5.  Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.

Authors:  Sachin Kunde; Angela Pham; Sarah Bonczyk; Teri Crumb; Meg Duba; Harold Conrad; Deborah Cloney; Subra Kugathasan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-06       Impact factor: 2.839

Review 6.  Fecal microbiota transplantation in the treatment of refractory Clostridium difficile infection in children: an update.

Authors:  Ritu Walia; Sachin Kunde; Lori Mahajan
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

Review 7.  Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life.

Authors:  Sushrut Jangi; J Thomas Lamont
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-07       Impact factor: 2.839

8.  Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Authors:  Suchitra K Hourigan; Sankar R Chirumamilla; Tracy Ross; Jonathan E Golub; Shervin Rabizadeh; Shehzad A Saeed; Charles O Elson; Ciaran P Kelly; Karen C Carroll; Maria Oliva-Hemker; Cynthia Sears
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

9.  Novel risk factors for recurrent Clostridium difficile infection in children.

Authors:  Maribeth R Nicholson; Isaac P Thomsen; James C Slaughter; C Buddy Creech; Kathryn M Edwards
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

10.  Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Yang Song; Shashank Garg; Mohit Girotra; Cynthia Maddox; Erik C von Rosenvinge; Anand Dutta; Sudhir Dutta; W Florian Fricke
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more
  20 in total

1.  Transitioning From Descriptive to Mechanistic Understanding of the Microbiome: The Need for a Prospective Longitudinal Approach to Predicting Disease.

Authors:  Victoria J Martin; Maureen M Leonard; Lauren Fiechtner; Alessio Fasano
Journal:  J Pediatr       Date:  2016-09-12       Impact factor: 4.406

Review 2.  The Central Nervous System and the Gut Microbiome.

Authors:  Gil Sharon; Timothy R Sampson; Daniel H Geschwind; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

3.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Zev H Davidovics; Sonia Michail; Maribeth R Nicholson; Larry K Kociolek; Nikhil Pai; Richard Hansen; Tobias Schwerd; Aldo Maspons; Raanan Shamir; Hania Szajewska; Nikhil Thapar; Tim de Meij; Alexis Mosca; Yvan Vandenplas; Stacy A Kahn; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

4.  Fecal microbiota transplantation in children does not significantly alter body mass index.

Authors:  Dong Xi; Sonia Michail
Journal:  Transl Pediatr       Date:  2019-12

Review 5.  The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood.

Authors:  John Slattery; Derrick F MacFabe; Richard E Frye
Journal:  Clin Med Insights Pediatr       Date:  2016-10-09

Review 6.  Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease.

Authors:  Alice Yuxin Wang; Jelena Popov; Nikhil Pai
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

Review 7.  The importance of appropriate initial bacterial colonization of the intestine in newborn, child, and adult health.

Authors:  W Allan Walker
Journal:  Pediatr Res       Date:  2017-05-17       Impact factor: 3.756

8.  Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in a Pediatric Heart Transplant Patient.

Authors:  Kyle L Flannigan; Taylor Rajbar; Andrew Moffat; Leanna S McKenzie; Frank Dicke; Kevin Rioux; Matthew L Workentine; Thomas J Louie; Simon A Hirota; Steven C Greenway
Journal:  Front Cardiovasc Med       Date:  2017-04-04

Review 9.  Clostridium difficile Infection in Special High-Risk Populations.

Authors:  Alberto Cózar-Llistó; Antonio Ramos-Martinez; Javier Cobo
Journal:  Infect Dis Ther       Date:  2016-08-11

Review 10.  Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.

Authors:  Jodie Ouahed; Elizabeth Spencer; Daniel Kotlarz; Dror S Shouval; Matthew Kowalik; Kaiyue Peng; Michael Field; Leslie Grushkin-Lerner; Sung-Yun Pai; Athos Bousvaros; Judy Cho; Carmen Argmann; Eric Schadt; Dermot P B Mcgovern; Michal Mokry; Edward Nieuwenhuis; Hans Clevers; Fiona Powrie; Holm Uhlig; Christoph Klein; Aleixo Muise; Marla Dubinsky; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2020-05-12       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.